-[4-(3-fleuro-3-methylbutyryloxy)but-2-ynyl]6α, 9α-difluoro-17α-(furan-2-yl) carbonyloxy-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9458187
SERIAL NO

14893655

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods of treatment of inflammatory conditions using S-[4-(3-fluoro-3-methylbutyryloxy)-but-2-ynyl]6α,9α-difluoro-17α-(furan-2-yl)carbonyloxy-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate (compound of formula I), a novel anti-inflammatory compound of the androstane series and its processes of preparation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITEDMUMBAI

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mandhane, Sanjay Nandlal Baroda, IN 2 1
Patel, Gopalkumar Chimanlal Baroda, IN 5 4
Patel, Jiten Ranchhodbhai Baroda, IN 5 4
Rao, Chitturi Trinadha Baroda, IN 2 12
Sheth, Gaurav Sanjivkumar Baroda, IN 6 4
Thennati, Rajamannar Baroda, IN 70 137

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 4, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00